Fidelity Advisor Biotechnology Fund - Class M (FBTTX)
| Fund Assets | 1.87B |
| Expense Ratio | 1.29% |
| Min. Investment | $0.00 |
| Turnover | 51.00% |
| Dividend (ttm) | 0.52 |
| Dividend Yield | 1.47% |
| Dividend Growth | -67.15% |
| Payout Frequency | Annual |
| Ex-Dividend Date | Dec 26, 2025 |
| Previous Close | 34.22 |
| YTD Return | -2.96% |
| 1-Year Return | 36.77% |
| 5-Year Return | 28.77% |
| 52-Week Low | 20.49 |
| 52-Week High | 36.93 |
| Beta (5Y) | n/a |
| Holdings | 88 |
| Inception Date | Dec 27, 2000 |
About FBTTX
Fidelity Advisor Biotechnology Fund - Class M is a mutual fund specializing in the biotechnology sector. Its primary objective is capital appreciation by investing at least 80% of its assets in companies that are primarily engaged in the research, development, manufacture, and distribution of biotechnology products, services, and processes, or those significantly benefiting from advances in biotechnology. The fund offers exposure to a range of both established and innovative biotech firms, with significant holdings in leading healthcare companies such as AbbVie, Gilead Sciences, and Amgen. With portfolio assets exceeding $1.3 billion, the fund is positioned as a focused vehicle for investors seeking diversified access to the growth and innovation of the biotech industry. It is managed by Fidelity Investments, known for its research-driven approach and strong management team. The fund plays a key role in the market for those aiming to participate in the dynamic and rapidly evolving biotechnology sector, which is instrumental in driving advancements across healthcare and pharmaceuticals.
Performance
FBTTX had a total return of 36.77% in the past year, including dividends. Since the fund's inception, the average annual return has been 11.05%.
Top 10 Holdings
53.99% of assets| Name | Symbol | Weight |
|---|---|---|
| AbbVie Inc. | ABBV | 17.22% |
| Alnylam Pharmaceuticals, Inc. | ALNY | 6.31% |
| Gilead Sciences, Inc. | GILD | 5.75% |
| argenx SE | ARGX | 4.55% |
| Ascendis Pharma A/S | ASND | 4.29% |
| Cogent Biosciences, Inc. | COGT | 3.98% |
| Insmed Incorporated | INSM | 3.40% |
| Viridian Therapeutics, Inc. | VRDN | 3.01% |
| Biogen Inc. | BIIB | 2.81% |
| Amgen Inc. | AMGN | 2.68% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 26, 2025 | $0.521 | Dec 29, 2025 |
| Dec 26, 2024 | $1.586 | Dec 27, 2024 |
| Dec 21, 2023 | $0.234 | Dec 22, 2023 |
| Dec 17, 2021 | $5.318 | Dec 20, 2021 |
| Jul 9, 2021 | $0.070 | Jul 12, 2021 |
| Dec 18, 2020 | $2.779 | Dec 21, 2020 |